Medirom Current Deferred Revenue vs Short Long Term Debt Total Analysis

MRM Stock

USD 2.64 0.06 2.22%

Medirom Healthcare financial indicator trend analysis is infinitely more than just investigating Medirom Healthcare recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medirom Healthcare is a good investment. Please check the relationship between Medirom Healthcare Current Deferred Revenue and its Short Long Term Debt Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Current Deferred Revenue vs Short Long Term Debt Total

Current Deferred Revenue vs Short Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medirom Healthcare Current Deferred Revenue account and Short Long Term Debt Total. At this time, the significance of the direction appears to have very week relationship.

The correlation between Medirom Healthcare's Current Deferred Revenue and Short Long Term Debt Total is 0.23. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of Medirom Healthcare Technologies, assuming nothing else is changed. The correlation between historical values of Medirom Healthcare's Current Deferred Revenue and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Medirom Healthcare Technologies are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Current Deferred Revenue i.e., Medirom Healthcare's Current Deferred Revenue and Short Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.23

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Short Long Term Debt Total

Most indicators from Medirom Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medirom Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

As of the 17th of November 2024, Enterprise Value is likely to grow to about 7.7 B, though Tax Provision is likely to grow to (89.7 M).

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	151.5M	184.1M	252.6M	135.8M
Interest Income	839K	6.1M	1.1M	2.0M

Depreciation And Amortization Interest Income

Medirom Healthcare fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Inventory
Total Assets		0.1	0.97	0.97	0.32	0.95	-0.71	0.3	-0.68	-0.14	-0.25	0.33	0.25	0.9	0.05	-0.42	0.96	0.21	-0.32	0.89	0.92	0.46	-0.91	0.93	-0.26	0.88
Short Long Term Debt Total	0.1		-0.03	0.22	-0.43	0.07	-0.5	0.87	0.23	0.95	0.55	0.29	-0.84	0.5	-0.38	0.49	0.14	-0.85	0.47	0.17	-0.1	0.54	-0.35	0.23	0.78	0.38
Other Current Liab	0.97	-0.03		0.96	0.25	0.95	-0.72	0.21	-0.79	-0.24	-0.46	0.41	0.35	0.85	-0.02	-0.43	0.97	0.32	-0.31	0.93	0.94	0.38	-0.83	0.93	-0.37	0.77
Total Current Liabilities	0.97	0.22	0.96		0.1	0.91	-0.85	0.46	-0.75	0.01	-0.31	0.53	0.09	0.94	-0.14	-0.24	0.97	0.05	-0.15	0.95	0.86	0.59	-0.92	0.97	-0.12	0.88
Total Stockholder Equity	0.32	-0.43	0.25	0.1		0.33	0.39	-0.55	0.05	-0.56	0.12	-0.55	0.59	0.05	0.57	-0.54	0.1	0.59	-0.43	0.03	0.45	-0.29	-0.08	-0.02	-0.67	0.19
Other Liab	0.95	0.07	0.95	0.91	0.33		-0.64	0.17	-0.61	-0.19	-0.31	0.22	0.37	0.87	0.06	-0.55	0.93	0.34	-0.37	0.86	0.96	0.21	-0.76	0.89	-0.4	0.73
Net Tangible Assets	-0.71	-0.5	-0.72	-0.85	0.39	-0.64		-0.76	0.7	-0.38	0.24	-0.8	0.33	-0.87	0.52	-0.1	-0.8	0.36	-0.17	-0.86	-0.53	-0.74	0.82	-0.86	-0.29	-0.74
Property Plant And Equipment Net	0.3	0.87	0.21	0.46	-0.55	0.17	-0.76		-0.13	0.83	0.32	0.57	-0.8	0.61	-0.42	0.49	0.39	-0.82	0.38	0.38	0.0	0.83	-0.63	0.49	0.82	0.6
Current Deferred Revenue	-0.68	0.23	-0.79	-0.75	0.05	-0.61	0.7	-0.13		0.3	0.73	-0.75	-0.24	-0.56	0.43	0.14	-0.7	-0.21	-0.01	-0.85	-0.66	-0.45	0.57	-0.69	0.33	-0.48
Net Debt	-0.14	0.95	-0.24	0.01	-0.56	-0.19	-0.38	0.83	0.3		0.51	0.34	-0.93	0.27	-0.46	0.72	-0.07	-0.93	0.66	0.01	-0.32	0.52	-0.15	0.01	0.86	0.16
Retained Earnings	-0.25	0.55	-0.46	-0.31	0.12	-0.31	0.24	0.32	0.73	0.51		-0.47	-0.54	-0.06	0.23	0.13	-0.36	-0.54	0.01	-0.48	-0.44	0.1	0.0	-0.29	0.58	0.14
Accounts Payable	0.33	0.29	0.41	0.53	-0.55	0.22	-0.8	0.57	-0.75	0.34	-0.47		-0.41	0.48	-0.82	0.48	0.42	-0.42	0.57	0.67	0.23	0.71	-0.43	0.47	0.26	0.33
Cash	0.25	-0.84	0.35	0.09	0.59	0.37	0.33	-0.8	-0.24	-0.93	-0.54	-0.41		-0.13	0.56	-0.77	0.21	1.0	-0.69	0.09	0.49	-0.61	0.1	0.1	-0.92	-0.13
Non Current Assets Total	0.9	0.5	0.85	0.94	0.05	0.87	-0.87	0.61	-0.56	0.27	-0.06	0.48	-0.13		-0.22	-0.15	0.89	-0.17	-0.03	0.89	0.77	0.6	-0.91	0.91	0.07	0.89
Non Currrent Assets Other	0.05	-0.38	-0.02	-0.14	0.57	0.06	0.52	-0.42	0.43	-0.46	0.23	-0.82	0.56	-0.22		-0.55	0.01	0.56	-0.77	-0.37	0.06	-0.42	0.03	-0.07	-0.3	0.01
Other Assets	-0.42	0.49	-0.43	-0.24	-0.54	-0.55	-0.1	0.49	0.14	0.72	0.13	0.48	-0.77	-0.15	-0.55		-0.35	-0.76	0.89	-0.15	-0.51	0.49	0.19	-0.33	0.64	-0.2
Long Term Debt	0.96	0.14	0.97	0.97	0.1	0.93	-0.8	0.39	-0.7	-0.07	-0.36	0.42	0.21	0.89	0.01	-0.35		0.18	-0.31	0.9	0.87	0.47	-0.89	0.98	-0.17	0.82
Cash And Short Term Investments	0.21	-0.85	0.32	0.05	0.59	0.34	0.36	-0.82	-0.21	-0.93	-0.54	-0.42	1.0	-0.17	0.56	-0.76	0.18		-0.68	0.05	0.46	-0.63	0.14	0.07	-0.92	-0.17
Net Receivables	-0.32	0.47	-0.31	-0.15	-0.43	-0.37	-0.17	0.38	-0.01	0.66	0.01	0.57	-0.69	-0.03	-0.77	0.89	-0.31	-0.68		0.04	-0.3	0.38	0.21	-0.29	0.41	-0.21
Good Will	0.89	0.17	0.93	0.95	0.03	0.86	-0.86	0.38	-0.85	0.01	-0.48	0.67	0.09	0.89	-0.37	-0.15	0.9	0.05	0.04		0.86	0.53	-0.79	0.88	-0.21	0.72
Common Stock Total Equity	0.92	-0.1	0.94	0.86	0.45	0.96	-0.53	0.0	-0.66	-0.32	-0.44	0.23	0.49	0.77	0.06	-0.51	0.87	0.46	-0.3	0.86		0.16	-0.67	0.79	-0.57	0.63
Common Stock Shares Outstanding	0.46	0.54	0.38	0.59	-0.29	0.21	-0.74	0.83	-0.45	0.52	0.1	0.71	-0.61	0.6	-0.42	0.49	0.47	-0.63	0.38	0.53	0.16		-0.73	0.52	0.56	0.72
Short Term Investments	-0.91	-0.35	-0.83	-0.92	-0.08	-0.76	0.82	-0.63	0.57	-0.15	0.0	-0.43	0.1	-0.91	0.03	0.19	-0.89	0.14	0.21	-0.79	-0.67	-0.73		-0.92	-0.15	-0.99
Non Current Liabilities Total	0.93	0.23	0.93	0.97	-0.02	0.89	-0.86	0.49	-0.69	0.01	-0.29	0.47	0.1	0.91	-0.07	-0.33	0.98	0.07	-0.29	0.88	0.79	0.52	-0.92		-0.04	0.85
Capital Lease Obligations	-0.26	0.78	-0.37	-0.12	-0.67	-0.4	-0.29	0.82	0.33	0.86	0.58	0.26	-0.92	0.07	-0.3	0.64	-0.17	-0.92	0.41	-0.21	-0.57	0.56	-0.15	-0.04		0.15
Inventory	0.88	0.38	0.77	0.88	0.19	0.73	-0.74	0.6	-0.48	0.16	0.14	0.33	-0.13	0.89	0.01	-0.2	0.82	-0.17	-0.21	0.72	0.63	0.72	-0.99	0.85	0.15

Click cells to compare fundamentals

Medirom Healthcare Account Relationship Matchups

Medirom Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.8B	5.7B	5.8B	6.7B	6.8B	6.3B
Short Long Term Debt Total	2.4B	1.9B	2.8B	2.5B	3.6B	2.9B
Other Current Liab	581.4M	1.7B	1.9B	2.6B	2.1B	1.7B
Total Current Liabilities	2.3B	2.7B	3.2B	3.6B	3.6B	3.2B
Total Stockholder Equity	600.1M	491.3M	(208.3M)	(59.4M)	210.9M	122.3M
Property Plant And Equipment Net	2.0B	1.8B	2.2B	2.4B	2.5B	2.4B
Current Deferred Revenue	483.1M	442.4M	104.2M	89.0M	512.0M	287.1M
Net Debt	1.8B	463.8M	2.4B	1.9B	3.5B	2.3B
Retained Earnings	(705.3M)	(1.7B)	(2.7B)	(2.5B)	80.3M	84.3M
Accounts Payable	122.6M	67.0M	230.9M	207.6M	137.7M	166.3M
Cash	513.6M	1.4B	370.6M	605.5M	106.3M	101.0M
Non Current Assets Total	3.4B	3.6B	4.4B	4.4B	5.1B	4.5B
Non Currrent Assets Other	987.3M	1.6B	107.2M	1.0B	1.1B	749.7M
Long Term Debt	150.5M	668.4M	746.6M	1.1B	1.1B	753.3M
Cash And Short Term Investments	552.1M	1.5B	397.1M	606.0M	106.8M	101.5M
Net Receivables	773.6M	148.5M	855.3M	534.7M	621.9M	476.9M
Good Will	78.3M	150.7M	600.3M	539.5M	484.6M	351.5M
Short Term Investments	38.5M	32.5M	26.5M	500K	450K	427.5K
Liabilities And Stockholders Equity	4.8B	5.7B	5.8B	6.7B	6.8B	6.3B
Non Current Liabilities Total	1.9B	2.6B	2.8B	3.2B	3.1B	2.9B
Capital Lease Obligations	1.8B	1.7B	1.9B	2.0B	2.1B	2.1B
Inventory	5.5M	8.0M	18.7M	114.1M	140.0M	147.0M
Other Current Assets	47.5M	458.5M	111.2M	1.1B	890.0M	486.9M
Total Liab	4.2B	5.2B	6.0B	6.8B	6.6B	6.1B
Net Invested Capital	1.1B	1.3B	700.5M	1.2B	1.8B	1.2B
Property Plant And Equipment Gross	2.0B	183.1M	2.4B	2.6B	2.8B	2.3B
Short Long Term Debt	371.6M	221.1M	162.3M	99.2M	500.4M	525.4M
Total Current Assets	1.4B	2.1B	1.4B	2.4B	1.8B	1.8B
Non Current Liabilities Other	5.6M	348.4M	25.2M	335.0M	271.7M	182.0M
Net Working Capital	(884.0M)	428.3M	(1.8B)	(1.3B)	(1.8B)	(1.9B)
Short Term Debt	1.1B	900.6M	917.5M	868.9M	1.3B	827.8M
Intangible Assets	77.6M	97.6M	391.0M	403.7M	920.7M	966.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:

How To Invest In Medirom

Details

Is Medirom Stock a good investment?

Details

What is Medirom Healthcare's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.582

Earnings Share

(0.15)

Revenue Per Share

1.4 K

Quarterly Revenue Growth

(0.06)

Return On Assets

(0.04)

The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medirom Current Deferred Revenue vs Short Long Term Debt Total Analysis

Current Deferred Revenue vs Short Long Term Debt Total

Current Deferred Revenue vs Short Long Term Debt Total Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Short Long Term Debt Total

Medirom Healthcare fundamental ratios Correlations

Medirom Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medirom Healthcare fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.98	Long Term Debt
Other Current Liab	+ 0.97	Total Assets
Total Current Liabilities	+ 0.97	Total Assets
Long Term Debt	+ 0.97	Other Current Liab
Long Term Debt	+ 0.97	Total Current Liabilities

Inventory	- 0.99	Short Term Investments
Cash And Short Term Investments	- 0.93	Net Debt
Cash	- 0.93	Net Debt
Non Current Liabilities Total	- 0.92	Short Term Investments
Capital Lease Obligations	- 0.92	Cash And Short Term Investments
Capital Lease Obligations	- 0.92	Cash